FDA on Real-World Data for Clinical Trial Regulatory Safety Studies
The 2024 DIA conference held a session on Harnessing Real-World Data to Generate Real-World Evidence for Clinical Trial Regulatory...
How Sanofi Incorporates Patient Data in Clinical Trials
At the recent Clinical Trial Outsourcing East Coast conference, Rachel Nering, Global Head of Early Development Clinical Operations at...
Key Takeaways From The White House Clinical Trials Forum
The White House Clinical Trials Forum brought together key leaders in science, healthcare, and patient advocacy to address the...
Genentech on Critical Thinking Skills in Clinical Trial Management
Importance of Critical Thinking Skills in Clinical Trial Management The 3rd Clinical Quality Oversight Conference, run by Momentum Events...
New Strategies for Effective Sponsor Oversight in Clinical Trials
The 3rd Clinical Quality Oversight Conference, run by Momentum Events in May of 2024, opened with a critical presentation...
Holistic Approach to GCP Compliance in African Malaria Clinical Trial
Leslie Sam, President, Leslie Sam and Associates, LLC and Lisa Collins, Co-Founder, Head of Clinical Research at Innomas Clinical...
ICH Shifts Strategy to Incorporate The Patient’s Persperctive
The ICH Townhall at the 2024 DIA Europe conference featured insightful discussions on the critical role of the International...
Exploring the State of Clinical Trials in Europe at DIA 2024
A 2024 DIA Europe Conference session led by Peter Richard Arlett, MD, Head of the Data Analytics and Methods...
Transforming Clinical Trials: The Surging Role of Regulatory Reliance
Regulatory reliance in regulatory frameworks refers to the practice where regulatory authorities use assessments conducted by other agencies to...
Eye-Opening FDA Strategies to Ensure Global Drug Safety
The FDA Town Hall at the 2024 DIA Europe Conference provided an insightful overview of the FDA’s strategic initiatives...